Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
公司代碼GELS
公司名稱Gelteq Ltd
上市日期Oct 29, 2024
CEOGivoni (Nathan Jacob)
員工數量7
證券類型Ordinary Share
年結日Oct 29
公司地址Level 4
城市MELBOURNE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Australia
郵編3205
電話61390873990
網址https://www.gelteq.com
公司代碼GELS
上市日期Oct 29, 2024
CEOGivoni (Nathan Jacob)